FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387379712> ?p ?o ?g. }

• W4387379712 abstract "Abstract Disclosure: S. Mohan: None. M.T. Sheehan: None. P.J. Tebben: None. R.A. Wermers: None. Introduction: Elevated 1,25-dihydroxyvitamin D (1,25(OH)2D) is a rare cause of non-parathyroid hormone (PTH) mediated hypercalcemia. An increase in the activating enzyme 1-alpha hydroxylase is seen in granulomatous diseases and lymphoma, while mutations in the CYP24A1 gene leads to reduced catabolism of 1,25(OH)2D. Cinacalcet has been shown to successfully treat 1,25(OH)2D-mediated hypercalcemia of malignancy. Extrapolating this, we report 3 patients with non-malignant 1,25(OH)2D-mediated hypercalcemia treated with cinacalcet. Case Series: The patients (2 male and 1 female) were 55-71 years old. At presentation to our clinic, all had hypercalcemia with serum calcium concentrations between 10.6-11.5 mg/dL (normal, 8.8-10.2 mg/dL). PTH ranged between 16-35 pg/ml (normal 15-65 pg/ml), PTH-related peptide was normal in all patients, 25-hydroxyvitamin D was 32-51 ng/ml, and 1,25(OH)2D was inappropriately normal between 31-77 pg/ml (normal 18-78 pg/mL) in the setting of hypercalcemia and chronic kidney disease in 2 patients with estimated glomerular filtration rates 35-42 ml/min. Other causes of hypercalcemia including sarcoidosis, tuberculosis and malignancy were ruled out. The female patient had hypercalciuria (288 mg/24 hours) without nephrolithiasis and both male patients had severe hypercalciuria (400-660 mg/24 hours) with recurrent nephrolithiasis. One male patient had biallelic variants in the CYP24A1 gene, while the other male patient was suspected to have similar mutations, but not identified on genetic testing. The female patient with a PTH of 35 pg/mL on our initial measurement had documented 1,25(OH)2D level of 82 pg/mL with PTH &lt;20 pg/mL while previously hypercalcemic. Upon cinacalcet initiation all patients demonstrated normalization of calcium levels (8.6-9.5 mg/dl) with doses between 30-90 mg daily. The patient with CYP24A1 gene mutations experienced symptomatic hypocalcemia with calcium of 8.1 mg/dL requiring dose reduction and eventual discontinuation of cinacalcet due to limited clinical benefit. There were no consistent changes in 24-hour urine calcium or fractional excretion of calcium. Levels of 1,25(OH)2D increased and PTH decreased on cinacalcet while serum calcium levels were maintained within normal range, including 2 subjects with continued normocalcemia after 2 years of therapy. Conclusion: Cinacalcet may be a therapeutic option in non-malignant 1,25(OH)2D-mediated hypercalcemia. Further evaluation is needed to confirm efficacy, understand risks and benefits, and elucidate potential mechanisms of action. Mild decrease in PTH may lead to reduced skeletal calcium efflux while the maintenance of normocalcemia despite rising 1,25(OH)2D, which was also seen in our reported patients with malignant 1,25(OH)2D-mediated hypercalcemia, suggests cinacalcet may decrease intestinal calcium absorption. Presentation: Saturday, June 17, 2023" @default.
• W4387379712 created "2023-10-06" @default.
• W4387379712 creator A5025335244 @default.
• W4387379712 creator A5039072842 @default.
• W4387379712 creator A5076667369 @default.
• W4387379712 creator A5079731206 @default.
• W4387379712 date "2023-10-01" @default.
• W4387379712 modified "2023-10-16" @default.
• W4387379712 title "SAT257 Efficacy Of Oral Cinacalcet In Non-PTH Non-Malignant Hypercalcemia From Excess 1,25 Dihydroxyvitamin D" @default.
• W4387379712 doi "https://doi.org/10.1210/jendso/bvad114.553" @default.
• W4387379712 hasPublicationYear "2023" @default.
• W4387379712 type Work @default.
• W4387379712 citedByCount "0" @default.
• W4387379712 crossrefType "journal-article" @default.
• W4387379712 hasAuthorship W4387379712A5025335244 @default.
• W4387379712 hasAuthorship W4387379712A5039072842 @default.
• W4387379712 hasAuthorship W4387379712A5076667369 @default.
• W4387379712 hasAuthorship W4387379712A5079731206 @default.
• W4387379712 hasBestOaLocation W43873797121 @default.
• W4387379712 hasConcept C124490489 @default.
• W4387379712 hasConcept C126322002 @default.
• W4387379712 hasConcept C134018914 @default.
• W4387379712 hasConcept C179639408 @default.
• W4387379712 hasConcept C2777724520 @default.
• W4387379712 hasConcept C2778838027 @default.
• W4387379712 hasConcept C2779399171 @default.
• W4387379712 hasConcept C2779674975 @default.
• W4387379712 hasConcept C2780534505 @default.
• W4387379712 hasConcept C2781208988 @default.
• W4387379712 hasConcept C2781301800 @default.
• W4387379712 hasConcept C519063684 @default.
• W4387379712 hasConcept C71924100 @default.
• W4387379712 hasConcept C76743606 @default.
• W4387379712 hasConcept C90924648 @default.
• W4387379712 hasConceptScore W4387379712C124490489 @default.
• W4387379712 hasConceptScore W4387379712C126322002 @default.
• W4387379712 hasConceptScore W4387379712C134018914 @default.
• W4387379712 hasConceptScore W4387379712C179639408 @default.
• W4387379712 hasConceptScore W4387379712C2777724520 @default.
• W4387379712 hasConceptScore W4387379712C2778838027 @default.
• W4387379712 hasConceptScore W4387379712C2779399171 @default.
• W4387379712 hasConceptScore W4387379712C2779674975 @default.
• W4387379712 hasConceptScore W4387379712C2780534505 @default.
• W4387379712 hasConceptScore W4387379712C2781208988 @default.
• W4387379712 hasConceptScore W4387379712C2781301800 @default.
• W4387379712 hasConceptScore W4387379712C519063684 @default.
• W4387379712 hasConceptScore W4387379712C71924100 @default.
• W4387379712 hasConceptScore W4387379712C76743606 @default.
• W4387379712 hasConceptScore W4387379712C90924648 @default.
• W4387379712 hasIssue "Supplement_1" @default.
• W4387379712 hasLocation W43873797121 @default.
• W4387379712 hasOpenAccess W4387379712 @default.
• W4387379712 hasPrimaryLocation W43873797121 @default.
• W4387379712 hasRelatedWork W1991503865 @default.
• W4387379712 hasRelatedWork W2115823637 @default.
• W4387379712 hasRelatedWork W2116694702 @default.
• W4387379712 hasRelatedWork W3014880330 @default.
• W4387379712 hasRelatedWork W3152517663 @default.
• W4387379712 hasRelatedWork W3199390182 @default.
• W4387379712 hasRelatedWork W3200170175 @default.
• W4387379712 hasRelatedWork W4206471014 @default.
• W4387379712 hasRelatedWork W4229370627 @default.
• W4387379712 hasRelatedWork W4309185781 @default.
• W4387379712 hasVolume "7" @default.
• W4387379712 isParatext "false" @default.
• W4387379712 isRetracted "false" @default.
• W4387379712 workType "article" @default.